osteoarthritis

X ray illustration of a running person with pain in knee joint with blue background
Biotech

Novartis culls ph. 2 knee pain trial testing anti-ADAMTS-5 asset

Novartis discontinued the study after an interim analysis found an “insufficient effect on pain relief,” a spokesperson said.
Gabrielle Masson Apr 16, 2025 2:55pm
In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

GSK pays AI biotech $45M upfront to identify fibrotic targets

Dec 10, 2024 4:59am
knee x-ray

Levicept's ex-Pfizer drug reduces osteoarthritis pain in ph. 2

Aug 6, 2024 1:00am
closed shuttered shut down closed

Ampio prepares to wind down after final therapeutic dream dies

Mar 26, 2024 9:01am
Missed target failed trial trial failure

Ampio’s last shot at success fizzles out in preclinical stage

Feb 15, 2024 7:10am
A man holds his knee in pain while sitting on a couch His shirt is blue and hes wearing brown pants

Seizure drug mechanism could treat osteoarthritis

Jan 5, 2024 10:22am